Dionex Corporation 

(Public, NASDAQ:DNEX)   Watch this stock   
Find more results for DNEX
Feb 9, 2010
Q2 2010 Earnings Conference Call - 4:30PM EST - Add to calendar
Feb 9, 2010
Q2 2010 Earnings Release
Jan 14, 2010
JPMorgan Healthcare Conference
Dec 1, 2009
Nasdaq OMX Investor Conference
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2009
Net profit margin 11.68% 14.40%
Operating margin 18.16% 21.88%
EBITD margin - 24.34%
Return on average assets 12.27% 16.79%
Return on average equity 18.31% 26.46%
Employees 1,400 -

Address

1228 Titan Way
Sunnyvale, CA 94085
United States - Map
+1-408-7370700 (Phone)
+1-408-7309403 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

Dionex Corporation discussions

  View all discussions »

Description

Dionex Corporation (Dionex) designs, manufactures, markets, and services analytical instrumentation, related accessories, and chemicals. Its products are used to analyze chemical substances in the environment and in a range of industrial and scientific applications. Dionex designs, manufactures, markets, and services a range of liquid chromatography systems, sample preparation devices, and related products used by chemists to separate and quantify the individual components of chemical mixtures relevant to many industrial, research, and laboratory markets. Its liquid chromatography systems are focused in two product areas: ion chromatography (IC) and high performance liquid chromatography (HPLC). Dionex offers a mass spectrometer detector coupled with either IC or HPLC systems. For sample preparation, it provides accelerated solvent extraction (ASE) systems and AutoTrace instruments. In addition, it develops and manufactures consumables, detectors, automation, and analysis systems.

Officers and directors

Frank Witney
President,Chief Executive Officer, Director
Age: 56
Bio & Compensation - Reuters
Craig McCollam
Chief Financial Officer, Executive Vice President - Finance and Administration
Age: 49
Bio & Compensation - Reuters
Bruce Barton
Executive Vice President - Global Sales and Service, Chief Commercial Officer
Age: 51
Bio & Compensation - Reuters
Christopher Pohl
Senior Vice President - Research and Development, Chief Science Officer
Age: 58
Bio & Compensation - Reuters
Peter Jochum
Senior Vice President - Life Sciences Business Unit
Age: 58
Bio & Compensation - Reuters
Dietrich Hauffe
Vice President - Corporate Marketing and Business Development
Age: 50
Bio & Compensation - Reuters
David Fairbanks
Vice President - Information Technology
Age: 48
Bio & Compensation - Reuters
John Plohetski
Vice President - Chemical Analysis Business Unit
Age: 51
Bio & Compensation - Reuters
Riccardo Pigliucci
Lead Director
Age: 62
Bio & Compensation - Reuters
David L. Anderson
Director
Age: 65
Bio & Compensation - Reuters